These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9835192)

  • 1. Evaluation of compartmental and spectral analysis models of [18F]FDG kinetics for heart and brain studies with PET.
    Bertoldo A; Vicini P; Sambuceti G; Lammertsma AA; Parodi O; Cobelli C
    IEEE Trans Biomed Eng; 1998 Dec; 45(12):1429-48. PubMed ID: 9835192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.
    Reivich M; Alavi A; Wolf A; Fowler J; Russell J; Arnett C; MacGregor RR; Shiue CY; Atkins H; Anand A
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):179-92. PubMed ID: 3988820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
    Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME
    J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noninvasive and simple method for the estimation of myocardial metabolic rate of glucose by PET and 18F-FDG].
    Takahashi N; Tamaki N; Kawamoto M; Magata Y; Okuda K; Nohara R; Sasayama S; Yonekura Y; Konishi J; Yamamoto K
    Kaku Igaku; 1994 Aug; 31(8):985-90. PubMed ID: 7933687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
    Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
    J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H; Gjedde A
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H; Evans AC; Gjedde A
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive determination of local cerebral metabolic rate of glucose in man.
    Huang SC; Phelps ME; Hoffman EJ; Sideris K; Selin CJ; Kuhl DE
    Am J Physiol; 1980 Jan; 238(1):E69-82. PubMed ID: 6965568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
    Uehara S; Kuwabara Y; Ichiya Y; Otsuka M; Ayabe Y; Miyake Y; Masuda K; Yoshimura A
    Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography.
    Sasaki H; Kanno I; Murakami M; Shishido F; Uemura K
    J Cereb Blood Flow Metab; 1986 Aug; 6(4):447-54. PubMed ID: 3488323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.